These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29616041)

  • 1. Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.
    Dekkers G; Rispens T; Vidarsson G
    Front Immunol; 2018; 9():553. PubMed ID: 29616041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities.
    Dekkers G; Treffers L; Plomp R; Bentlage AEH; de Boer M; Koeleman CAM; Lissenberg-Thunnissen SN; Visser R; Brouwer M; Mok JY; Matlung H; van den Berg TK; van Esch WJE; Kuijpers TW; Wouters D; Rispens T; Wuhrer M; Vidarsson G
    Front Immunol; 2017; 8():877. PubMed ID: 28824618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
    Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
    J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice.
    Dekkers G; Bentlage AEH; Plomp R; Visser R; Koeleman CAM; Beentjes A; Mok JY; van Esch WJE; Wuhrer M; Rispens T; Vidarsson G
    Mol Immunol; 2018 Feb; 94():54-60. PubMed ID: 29268168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
    PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG-effector functions: "the good, the bad and the ugly".
    Kapur R; Einarsdottir HK; Vidarsson G
    Immunol Lett; 2014 Aug; 160(2):139-44. PubMed ID: 24495619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.
    Lee CH; Romain G; Yan W; Watanabe M; Charab W; Todorova B; Lee J; Triplett K; Donkor M; Lungu OI; Lux A; Marshall N; Lindorfer MA; Goff OR; Balbino B; Kang TH; Tanno H; Delidakis G; Alford C; Taylor RP; Nimmerjahn F; Varadarajan N; Bruhns P; Zhang YJ; Georgiou G
    Nat Immunol; 2017 Aug; 18(8):889-898. PubMed ID: 28604720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.
    Sonneveld ME; de Haas M; Koeleman C; de Haan N; Zeerleder SS; Ligthart PC; Wuhrer M; van der Schoot CE; Vidarsson G
    Sci Rep; 2017 Aug; 7(1):8187. PubMed ID: 28811589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases.
    Li D; Lou Y; Zhang Y; Liu S; Li J; Tao J
    Theranostics; 2021; 11(11):5430-5446. PubMed ID: 33859756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
    Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
    J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
    Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
    J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity.
    Peschke B; Keller CW; Weber P; Quast I; Lünemann JD
    Front Immunol; 2017; 8():646. PubMed ID: 28634480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.
    Lilienthal GM; Rahmöller J; Petry J; Bartsch YC; Leliavski A; Ehlers M
    Front Immunol; 2018; 9():958. PubMed ID: 29867943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation.
    Wei B; Gao X; Cadang L; Izadi S; Liu P; Zhang HM; Hecht E; Shim J; Magill G; Pabon JR; Dai L; Phung W; Lin E; Wang C; Whang K; Sanchez S; Oropeza J; Camperi J; Zhang J; Sandoval W; Zhang YT; Jiang G
    MAbs; 2021; 13(1):1893427. PubMed ID: 33682619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.
    Sondermann P
    J Clin Immunol; 2016 May; 36 Suppl 1():95-9. PubMed ID: 27039179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.
    Subedi GP; Barb AW
    MAbs; 2016; 8(8):1512-1524. PubMed ID: 27492264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of complement component C1q to anti-beta2 glycoprotein I antibodies from patients with antiphospholipid syndrome.
    Odorczuk M; Keil LB; DeBari VA
    Inflamm Res; 1999 Oct; 48(10):524-6. PubMed ID: 10563468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies.
    Fernandes-Cerqueira C; Renard N; Notarnicola A; Wigren E; Gräslund S; Zubarev RA; Lundberg IE; Lundström SL
    Sci Rep; 2018 Dec; 8(1):17958. PubMed ID: 30560888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the galactose content of IgG during humoral immune responses.
    Lastra GC; Thompson SJ; Lemonidis AS; Elson CJ
    Autoimmunity; 1998; 28(1):25-30. PubMed ID: 9754811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.